Lissencephaly type 3-familial fetal akinesia sequence syndrome is a very rare genetic condition that affects brain development and movement before birth. Many living with Lissencephaly type 3-familial fetal akinesia sequence syndrome are recognized during pregnancy or at birth because reduced fetal movement and severe structural differences are seen. Early signs of Lissencephaly type 3-familial fetal akinesia sequence syndrome can include little or no movement in the womb, joint contractures, and serious brain malformations. Not everyone will have the same experience, but this condition is typically severe, lifelong, and often life-limiting in infancy or early childhood. Treatment focuses on supportive care, which may include breathing support, feeding help, seizure treatment when needed, and comfort-focused care.
How many people live with Lissencephaly type 3-familial fetal akinesia sequence syndrome?
Lissencephaly type 3-familial fetal akinesia sequence syndrome is so rare that reliable worldwide and U.S. counts are not consistently reported by a single authoritative source. Major rare-disease references such as Orphanet and OMIM describe it as an extremely rare genetic condition, but they do not provide firm recent estimates for how many people are living with it worldwide or in the United States.
Overview
Lissencephaly type 3-familial fetal akinesia sequence syndromeSymptoms
Lissencephaly type 3-familial fetal akinesia sequence syndrome is usually recognized before birth or at delivery. Main signs include very little fetal movement, severe brain malformation with a smooth brain surface, joint contractures, muscle weakness, and often breathing or feeding problems.
Outlook and prognosis
Lissencephaly type 3-familial fetal akinesia sequence syndrome is usually severe. Many affected babies have major brain, breathing, and movement problems from birth, and life expectancy is often short. Prognosis can vary with the exact gene change and organ involvement.
Causes and risk factors
Lissencephaly type 3-familial fetal akinesia sequence syndrome is caused by harmful genetic changes, often inherited in an autosomal recessive pattern, meaning both parents usually carry one changed copy. Family history raises risk; lifestyle or environmental factors are not known primary causes.
Genetic influences
Genetics are central to Lissencephaly type 3-familial fetal akinesia sequence syndrome. It is usually caused by harmful gene changes, often inherited, that disrupt early brain and muscle development before birth.
Diagnosis
Diagnosis of Lissencephaly type 3-familial fetal akinesia sequence syndrome starts with ultrasound or MRI findings and clinical features seen before or at birth. Doctors often confirm the genetic diagnosis of Lissencephaly type 3-familial fetal akinesia sequence syndrome with genetic testing.
Treatment and drugs
For lissencephaly type 3-familial fetal akinesia sequence syndrome, care focuses on comfort and daily needs. Many need help with feeding, breathing, and seizures. Physical therapy and coordinated neurologic, lung, and nutrition care can support families.
Symptoms
During pregnancy, one of the first clues may be that the baby moves much less than expected. Lissencephaly type 3-familial fetal akinesia sequence syndrome is a rare inherited condition that affects brain development before birth and can also affect the joints, feeding, and breathing. Some of the early features of Lissencephaly type 3-familial fetal akinesia sequence syndrome can be seen on pregnancy scans, while others become clearer at birth or soon after.
During pregnancy, the baby may move very little or less often than expected. Ultrasound may also show the baby staying in one position for long periods, sometimes with extra fluid around the baby.
In Lissencephaly type 3-familial fetal akinesia sequence syndrome, the brain may have too few folds and look unusually smooth on scans. This change is closely linked with severe problems in movement, learning, and seizure control.
Many babies have a head that is smaller than expected before birth or at delivery. This usually reflects reduced brain growth rather than a problem with the skull bones themselves.
Arms, legs, hands, or feet may be fixed in certain positions at birth, making movement harder. Doctors call these contractures, and they can affect holding, dressing, and other daily care.
How people usually first notice Lissencephaly type 3-familial fetal akinesia sequence syndrome?
Lissencephaly type 3-familial fetal akinesia sequence syndrome is usually first noticed during pregnancy, when ultrasound shows that the fetus is moving much less than expected, often with stiff joints, poor growth, or extra fluid buildup that suggests the body is not developing in the usual way. After birth, the first signs of Lissencephaly type 3-familial fetal akinesia sequence syndrome may include severe muscle weakness, trouble breathing or feeding, and multiple joint contractures, which means the joints are fixed in a bent or straight position. Doctors may then confirm the diagnosis with brain imaging, which can show lissencephaly, a smooth brain surface caused by abnormal brain development before birth.
Types of Lissencephaly type 3-familial fetal akinesia sequence syndrome
No distinct types of Lissencephaly type 3-familial fetal akinesia sequence syndrome are widely recognized.
Can I slow down the onset of symptoms?
No. With lissencephaly type 3-familial fetal akinesia sequence syndrome, the changes that cause the condition happen very early in pregnancy, so there is no proven lifestyle change, medicine, or other treatment that can delay symptoms from starting, and there is no known way to prevent it once a pregnancy is affected. If this condition runs in your family, meeting with a genetics specialist before or during pregnancy and considering family testing may help clarify the chance in a future pregnancy, even though it does not slow or stop the condition itself.
What genetics can tell you about symptoms
In lissencephaly type 3 with familial fetal akinesia sequence syndrome, genetics can help explain why symptoms often begin very early, usually before birth, and why movement in the womb may be reduced. Different disease-causing gene changes can influence how the brain develops and how severely the muscles, joints, breathing, and feeding are affected, so some families may see a somewhat different pattern or degree of symptoms. Even so, genetics cannot always predict every symptom in one baby, because severity can vary even among people with changes in the same gene.
Causes and risk factors
For many families, the first clue is that a baby moves much less than expected during pregnancy, and scans may show brain changes. Lissencephaly type 3-familial fetal akinesia sequence syndrome is caused by a gene change that is present before birth. It is often inherited within a family, and risk is higher when both parents carry the same altered gene. No clear lifestyle choice or common environmental exposure is known to cause this syndrome. Genetic testing can sometimes clarify your personal risk.
What are the most common causes or risk factors?
Lissencephaly type 3-familial fetal akinesia sequence syndrome is usually caused by rare inherited gene changes that disrupt a baby's brain and movement development before birth. The main risk factors are a family history of the condition, both parents carrying the same rare changed gene, and parents being blood relatives, such as cousins, which makes this more likely. There are no well-proven lifestyle or pregnancy-related causes for this syndrome.
Environmental and biological risk factors
For Lissencephaly type 3-familial fetal akinesia sequence syndrome, doctors have not identified clear environmental or non-genetic biological risk factors. Doctors often group risks into internal (biological) and external (environmental), but in this rare condition those links remain poorly defined. In practical terms, no specific pregnancy exposure, maternal illness, or age-related factor has been proven to be a main cause.
No infection, medication, food, or chemical exposure has been consistently shown to cause Lissencephaly type 3-familial fetal akinesia sequence syndrome. Because the condition is so rare, researchers cannot point to one avoidable exposure with confidence.
Common maternal health conditions, such as diabetes, high blood pressure, or thyroid disease, are not established causes of this syndrome. They still matter for overall pregnancy care, but they have not been specifically tied to this condition.
Older maternal or paternal age is not a well-established risk factor for Lissencephaly type 3-familial fetal akinesia sequence syndrome. This is different from some chromosome conditions, where age clearly changes the chance of the condition occurring.
High-dose radiation and toxic exposures can affect fetal development in general. However, they have not been specifically proven to trigger this syndrome.
Genetic risk factors
For families facing this diagnosis, one of the first questions is why it happened and whether it could happen again. Lissencephaly type 3-familial fetal akinesia sequence syndrome is usually linked to rare inherited gene changes that disrupt very early brain development and fetal movement before birth. In many reported families, the inheritance pattern appears autosomal recessive, meaning both parents carry one changed copy without knowing it. Because this condition is so rare, the genetic causes of Lissencephaly type 3-familial fetal akinesia sequence syndrome are not fully identified in every family.
Rare gene changes: This syndrome is thought to result from harmful changes in genes that help the brain and movement system develop in the fetus. In some families, the exact gene has not yet been found, even when the condition clearly appears to be genetic.
Recessive inheritance: Many living with this syndrome come from families where the condition follows an autosomal recessive pattern. This means the baby inherits two non-working copies of the same gene, one from each parent.
Carrier parents: Parents who carry one changed copy are usually healthy and often have no warning signs themselves. If both parents carry the same recessive change, each pregnancy has a 25% chance of being affected.
Family history: Having a previous affected pregnancy or child raises the chance that the same genetic change is present in the family. Knowledge can help families feel more prepared and less anxious. Genetic counseling can help explain the recurrence risk for future pregnancies.
Related parents: When parents are biologically related, they are more likely to carry the same rare recessive gene change. This can increase the risk of very rare inherited conditions, including Lissencephaly type 3-familial fetal akinesia sequence syndrome.
Lifestyle risk factors
Lissencephaly type 3-familial fetal akinesia sequence syndrome is a genetic condition, so lifestyle habits do not cause it. However, daily care choices can still influence comfort, symptom control, and the risk of complications. When people ask about lifestyle risk factors for Lissencephaly type 3-familial fetal akinesia sequence syndrome, the most helpful focus is how lifestyle affects Lissencephaly type 3-familial fetal akinesia sequence syndrome in day-to-day management.
Poor feeding routines or unsafe swallowing management can raise the risk of choking, aspiration, and poor growth. Careful feeding plans, texture adjustments, and specialist guidance can improve nutrition and reduce respiratory complications.
The condition itself limits movement, but regular physiotherapy, stretching, and supported positioning may help reduce contractures and discomfort. Long periods without guided movement can worsen stiffness, pressure injury risk, and loss of joint mobility.
Infrequent repositioning can increase the chance of pressure sores, pain, and worsening body asymmetry. Consistent supportive seating, lying positions, and posture management can improve comfort and protect skin and joints.
Weak movement and swallowing problems can make mucus clearance harder, so missed airway clearance routines may increase chest infections. Chest physiotherapy, suctioning when needed, and attention to breathing support can help maintain lung function.
Risk prevention
Lissencephaly type 3-familial fetal akinesia sequence syndrome is a rare inherited condition, so there is usually no way to prevent the condition itself once a pregnancy is affected. For families with a known gene change or a previously affected pregnancy, prevention mainly means genetic counseling before or early in pregnancy and discussing testing options. During pregnancy, care focuses on spotting complications early and supporting the health of the pregnant person and baby. Different people need different prevention strategies—there’s no single formula.
If this condition has happened in your family before, meeting with a genetics specialist before pregnancy can help clarify the chance of it happening again. This can guide choices about carrier testing, reproductive planning, and early pregnancy care.
When the disease-causing gene in a family is known, testing parents or other relatives may identify who carries it. This cannot prevent the gene change itself, but it can help families make informed decisions before conception.
Some families choose options such as IVF with embryo testing or the use of donor egg or donor sperm to lower the chance of another affected pregnancy. Talk to your doctor about which preventive steps are right for you.
In a pregnancy at higher risk, early testing such as chorionic villus sampling or amniocentesis may show whether the fetus has the known familial gene change. This does not treat lissencephaly type 3-familial fetal akinesia sequence syndrome, but it can provide answers early and help plan care.
Can you prevent Lissencephaly type 3-familial fetal akinesia sequence syndrome?
Usually, no. This is a very rare inherited condition caused by changes in genes, so there is no known way to prevent it with diet, medicines, or lifestyle changes during pregnancy. If it runs in your family, genetic counseling and, in some cases, testing before or during pregnancy may help you understand the chance in a future pregnancy, but they do not prevent the condition itself.
Transmission
Lissencephaly type 3-familial fetal akinesia sequence syndrome is not infectious, so it cannot spread from one person to another through touch, coughing, sex, blood, food, or other everyday contact. It is a rare genetic condition that develops before birth.
In the families described so far, how Lissencephaly type 3-familial fetal akinesia sequence syndrome is inherited appears to fit a recessive pattern, meaning a baby is affected only if they receive a changed copy of the gene from both parents. The parents are often healthy carriers, and if both carry the gene change, each pregnancy has a 1 in 4, or 25%, chance of being affected.
When to test your genes
Genetic testing is most useful before or during pregnancy if your family has a history of this syndrome, a previous affected pregnancy, or ultrasound findings such as reduced fetal movement, joint contractures, or major brain differences. Early testing can clarify recurrence risk and guide prenatal care, delivery planning, and genetic counseling.
Diagnosis
Lissencephaly type 3-familial fetal akinesia sequence syndrome is usually suspected before birth or soon after delivery because the baby has a pattern of severe movement and brain development changes. Diagnosis often starts when scans show reduced fetal movement, joint contractures, or brain differences, and then doctors use more detailed tests to confirm the cause. Getting a diagnosis is often a turning point toward answers and support. The genetic diagnosis of lissencephaly type 3-familial fetal akinesia sequence syndrome combines imaging findings, the baby’s clinical features, and genetic testing.
Doctors may first suspect this condition during pregnancy when ultrasound shows very little fetal movement, stiff joints, or a baby staying in one position for long periods. The scan may also show growth concerns or other structural differences that suggest a serious developmental disorder.
A fetal MRI can give a clearer picture of the brain when ultrasound raises concern. It may show a smooth brain surface, abnormal brain folds, or other findings that support the diagnosis of lissencephaly type 3-familial fetal akinesia sequence syndrome.
After birth, doctors look for features linked to reduced movement before birth, such as joint contractures, muscle weakness, or trouble breathing on their own. They also assess tone, reflexes, and feeding, because these findings help show how broadly the condition is affecting the body.
MRI of the brain is one of the most important tests for confirming lissencephaly and related brain malformations. It helps doctors see how the brain formed and can distinguish this syndrome from other causes of decreased fetal movement or severe neurologic disease.
How is Lissencephaly type 3-familial fetal akinesia sequence syndrome diagnosed?
Lissencephaly type 3-familial fetal akinesia sequence syndrome is usually suspected before birth when ultrasound shows very little fetal movement, joint stiffness or fixed limb positions, and signs that the brain surface is unusually smooth; a more detailed scan, such as fetal MRI, may help show these changes more clearly. After birth, doctors look at the baby's movement, muscle tone, and physical features, and they use brain imaging to confirm the pattern of brain development. Genetic testing can help confirm the diagnosis and explain the cause, but it is usually used alongside the scan findings and exam rather than by itself.
Stages of Lissencephaly type 3-familial fetal akinesia sequence syndrome
Lissencephaly type 3-familial fetal akinesia sequence syndrome does not have defined progression stages. This is because it is a condition that develops before birth, rather than one that usually moves through clear step-by-step phases over time. Doctors usually start with a conversation about pregnancy history, ultrasound findings, and symptoms seen at birth, and the diagnosis is usually supported by brain imaging and genetic testing. In many families, the early symptoms of Lissencephaly type 3-familial fetal akinesia sequence syndrome are first recognized during pregnancy because of reduced fetal movement and growth concerns.
Outlook and prognosis
The outlook for lissencephaly type 3-familial fetal akinesia sequence syndrome is generally very poor because the condition reflects severe abnormalities of brain development combined with markedly reduced fetal movement and often major birth defects. Many affected pregnancies end in miscarriage, stillbirth, or death around the time of birth, and among liveborn infants survival is often limited. When babies do survive, they usually have profound neurologic impairment, severe developmental limitations, feeding and breathing difficulties, and a very high need for intensive supportive care. Mortality is high in the neonatal period and early infancy, most often related to respiratory complications and the overall severity of the malformations. Because only a very small number of affected families have been reported, the exact life expectancy is not well defined, but long-term survival appears to be rare. Genetic counseling is important for families, since recurrence risk may be significant depending on the underlying inherited cause.
Long-term effects
For families affected by Lissencephaly type 3-familial fetal akinesia sequence syndrome, the long-term picture is often shaped very early in pregnancy or around birth. This condition is usually extremely severe, and many affected babies do not survive to delivery or live only a short time after birth. In the rare infants who survive longer, the outlook is dominated by profound brain and body involvement rather than gradual improvement. Long-term effects vary widely, but severe disability is expected in those who live beyond the newborn period.
The most serious long-term effect is a very high risk of death before birth or in the newborn period. This means prognosis is often poor from the start, with only rare longer-term survivors reported.
The brain changes are severe and can lead to profound developmental impairment in survivors. Many living with Lissencephaly type 3-familial fetal akinesia sequence syndrome would be expected to have little or no typical progress in movement, communication, or learning.
Reduced movement before birth often goes along with marked muscle weakness, stiff joints, or contractures that persist after delivery. For many, this can mean very limited voluntary movement and a need for full physical support.
Weak muscles and poor control of breathing can cause major respiratory problems from birth onward. These issues are one reason survival is often short in this condition.
How is it to live with Lissencephaly type 3-familial fetal akinesia sequence syndrome?
Living with lissencephaly type 3-familial fetal akinesia sequence syndrome is usually marked by very serious medical needs from birth, because the condition affects brain development and movement before birth and often leads to severe muscle weakness, feeding problems, breathing difficulties, seizures, and profound developmental impairment. For many families, daily life centers on round-the-clock care, frequent medical visits, and support with feeding, comfort, positioning, and respiratory needs, and in some children the condition is life-limiting. This can deeply affect parents, siblings, and other loved ones, who often carry both the practical demands of intensive caregiving and the emotional weight of living with great uncertainty, while also finding meaning in comfort, connection, and small day-to-day moments.
Treatment and drugs
Lissencephaly type 3-familial fetal akinesia sequence syndrome is a very severe condition that starts before birth, so treatment focuses on comfort, safety, and supporting breathing, feeding, and overall daily care rather than curing the underlying brain changes. Care often involves a team that may include newborn specialists, neurologists, lung and feeding experts, physical and occupational therapists, and palliative care clinicians, because babies living with this condition can have major problems with movement, muscle tone, swallowing, and seizures. Treatment plans often combine several approaches. This can include medicines to help control seizures, breathing support if needed, tube feeding when sucking or swallowing is unsafe, careful positioning to prevent pressure injuries and joint stiffness, and treatment for infections or other complications as they come up. Support from family or friends can make daily treatment easier, and genetic counseling is often offered to help families understand the diagnosis, what care may be needed, and future pregnancy risks.
Can you cure Lissencephaly type 3-familial fetal akinesia sequence syndrome?
No, there is currently no cure for lissencephaly type 3-familial fetal akinesia sequence syndrome, and treatment cannot reverse the brain and body changes it causes before birth. Care focuses on support, such as help with feeding, breathing, seizures, movement problems, and comfort. Many families work with a team of specialists to manage symptoms and improve quality of life as much as possible.
Non-drug treatment
Daily care for people living with Lissencephaly type 3-familial fetal akinesia sequence syndrome usually centers on comfort, breathing, feeding, movement, and family support rather than a single therapy. Because this condition can affect the brain, muscles, joints, and lungs from birth, non-drug care is often delivered by a team and adjusted over time. Some babies need intensive supportive care early, while others may benefit from therapies that help with positioning, communication, and day-to-day comfort. Not every approach works the same way, so care is tailored to each child’s needs and overall health.
Breathing support may include oxygen, suctioning, airway clearance, and sometimes noninvasive ventilation if breathing is weak. For many, treatment begins not at the pharmacy, but with keeping the airway clear, reducing chest infections, and making breathing more comfortable.
Feeding therapy can help with sucking and swallowing, while some children need tube feeding to get enough nutrition safely. This can lower the risk of choking or food going into the lungs, which is a common concern in the early symptoms of Lissencephaly type 3-familial fetal akinesia sequence syndrome.
Gentle stretching, range-of-motion work, and guided movement can help prevent worsening stiffness and contractures. Many living with Lissencephaly type 3-familial fetal akinesia sequence syndrome may also use positioning routines to support comfort and easier daily care.
Occupational therapy focuses on posture, seating, splints, and ways to make care tasks safer and easier. Supportive therapies can help protect the joints, improve comfort, and support participation as much as possible.
Your genes may have an impact on how drugs work for you
For people living with lissencephaly type 3-familial fetal akinesia sequence syndrome, there is no well-established proof that the genetic change causing the condition also clearly predicts how common medicines will work or what side effects they will cause. In day-to-day care, medicines are usually chosen based on the problems a child is having, such as seizures, feeding trouble, or muscle stiffness, and doctors adjust treatment by watching closely to see what helps and what does not. This means drug response is guided more by the person’s symptoms and overall health than by a known inherited pattern for this condition.
Pharmacological treatments
Care usually centers on comfort and day-to-day symptoms, because there is no medicine that can reverse the underlying changes in lissencephaly type 3-familial fetal akinesia sequence syndrome. If a baby survives after birth, doctors may use drugs for problems such as seizures, muscle stiffness, reflux, constipation, or heavy secretions. Drug treatments are not about fixing everything at once, but about easing symptoms and supporting feeding, breathing, and comfort.
If seizures occur, doctors often use anti-seizure drugs such as levetiracetam, phenobarbital, or valproic acid, depending on the child’s age and overall condition. The best seizure treatment for lissencephaly type 3-familial fetal akinesia sequence syndrome varies, and more than one medicine may be needed.
Baclofen or diazepam may be used when increased muscle tone, spasms, or discomfort make handling and positioning harder. These medicines can help some babies relax more comfortably, but they may also cause sleepiness or affect breathing.
Omeprazole, lansoprazole, or famotidine may be prescribed if feeding is difficult because of reflux or irritation from stomach acid. Treatment aims to reduce pain and spit-up, although medicines do not fully solve swallowing problems.
Polyethylene glycol, lactulose, or glycerin suppositories are commonly used when constipation becomes a problem. Keeping stools soft can make feeding and daily care easier and may reduce belly discomfort.
Genetic influences
Because this syndrome tends to appear in families, its cause is genetic rather than something a parent did during pregnancy. In reported families, Lissencephaly type 3-familial fetal akinesia sequence syndrome has shown an autosomal recessive inheritance pattern, meaning a baby is affected only when both copies of the relevant gene are altered. Parents are usually healthy carriers, each with one altered copy. These gene changes interfere with very early brain development and can reduce fetal movement before birth, which helps explain why the brain changes and fetal akinesia occur together. Understanding whether a condition is inherited can guide next steps. After one affected pregnancy, genetic counseling and genetic testing for Lissencephaly type 3-familial fetal akinesia sequence syndrome may help a family understand the chance of it happening again.
Is Lissencephaly type 3-familial fetal akinesia sequence syndrome genetic?
Genetics are central to Lissencephaly type 3-familial fetal akinesia sequence syndrome. It is usually caused by harmful gene changes, often inherited, that disrupt early brain and muscle development before birth.
Having a genetic risk is not necessarily a diagnosis
Changes in genes, called genetic variants, are a normal part of being human and are widespread across the general population. Most of these variants do not directly affect health and are simply one part of natural human variation. In many genes, having a variant connected with a condition points to a possible link, not a certain diagnosis, particularly when several genes and environmental influences play a role. In other situations, though, one well-understood variant in a particular gene may be enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
For families affected by lissencephaly type 3-familial fetal akinesia sequence syndrome, treatment is usually about breathing support, feeding, seizure care, and comfort, not a drug that can correct the underlying genetic change. In practice, doctors choose medicines based on the problems a baby has, such as seizures or muscle stiffness, and on safety issues like swallowing, breathing, and how medically fragile the child is overall. Not every difference in response is genetic, but in lissencephaly type 3-familial fetal akinesia sequence syndrome, the main role of genetic testing is to confirm the diagnosis and show which body systems may need closer follow-up. At this time, there is no well-established gene-based medication that specifically treats lissencephaly type 3-familial fetal akinesia sequence syndrome, and there is no standard pharmacogenetic test that reliably predicts which seizure or comfort medicine will work best. Still, a genetic diagnosis can help families and care teams avoid unnecessary testing, make more informed decisions about supportive treatments, and discuss whether research studies or experimental approaches may be relevant. If you are discussing genetic testing for lissencephaly type 3-familial fetal akinesia sequence syndrome, it is reasonable to ask how the result may change day-to-day care, emergency planning, and future family planning.
Interactions with other conditions
Children with Lissencephaly type 3-familial fetal akinesia sequence syndrome often have medical problems that affect each other rather than happening in isolation. Weak movement before birth and ongoing muscle weakness can go along with joint contractures, feeding trouble, and breathing problems, so an illness such as a chest infection may hit harder and recovery can take longer. Doctors call it a comorbidity when two conditions occur together. In daily life, this can mean reflux or swallowing problems raise the risk of food or liquid going into the airway, which can lead to aspiration and pneumonia. Some living with Lissencephaly type 3-familial fetal akinesia sequence syndrome also develop seizures, and seizure medicines may need careful adjustment if there is poor feeding, liver problems, or sleep-related breathing issues. Because the early symptoms of Lissencephaly type 3-familial fetal akinesia sequence syndrome can overlap with signs of other neurologic or muscle disorders, coordinated care between neurology, pulmonology, nutrition, and physical therapy is often important.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Lissencephaly type 3-familial fetal akinesia sequence syndrome?
Conditions most often considered include other disorders that cause a smooth brain and severe brain development problems, such as Miller-Dieker syndrome, as well as conditions in the fetal akinesia group, where a baby moves very little before birth and may be born with stiff joints, such as Pena-Shokeir syndrome. Some severe muscle, nerve, or chromosome conditions can also look similar early on, so doctors usually use ultrasound, brain scans, and genetic testing to tell them apart.
History
Families and communities once noticed patterns of pregnancies in which a baby moved very little before birth, often followed by serious problems with brain development and other complications. Long before doctors had today’s imaging tools, these cases were usually described only by what could be seen at delivery or during pregnancy loss, so they were often grouped with other severe fetal movement disorders rather than recognized as a distinct condition.
As medical science evolved, ultrasound and later MRI helped doctors connect reduced fetal movement with changes in the developing brain, including a very smooth brain surface, known medically as lissencephaly. That made it easier to separate conditions that had once been lumped together. What is now called Lissencephaly type 3-familial fetal akinesia sequence syndrome emerged from this process, as specialists began to notice a repeated pattern in some families: very limited fetal movement, joint stiffness or fixed positions before birth, and major brain malformations.
Early reports were based mostly on physical findings and pregnancy history, so the condition was not always named the same way from one paper to another. Some cases were described under broader labels for fetal akinesia, while others were filed under types of lissencephaly. Over time, the way the condition has been understood has changed, and this matters because clearer classification helps families get more accurate counseling and helps doctors compare similar cases.
In more recent decades, careful review of family patterns, prenatal scans, and laboratory research showed that this syndrome is part of a small group of inherited conditions that affect early brain and body movement development before birth. Researchers later identified a genetic cause, which confirmed that these recurring family cases were not random. Today, the history of this condition reflects a wider shift in medicine: moving from describing what doctors could observe to understanding why those findings happen together.
Knowing this history can make the early symptoms of Lissencephaly type 3-familial fetal akinesia sequence syndrome a little easier to place in context. For many living through an affected pregnancy, the first clues are not abstract medical terms but everyday observations on a scan, such as very little movement or limbs staying in one position. The name may be rare, but the medical understanding behind it has grown steadily over time.